Skip to main content
. 2020 Mar 30;12(6):4815–4821. doi: 10.18632/aging.102897

Table 3. Univariate and multivariate analysis of prognostic factors in TET.

Variable Univariate Multivariate
HR (95% CI) P value HR (95% CI) P value
Age group 0.001 0.001
0-18 1.102 (95% CI: 0.633-1.916) 0.732 1.079 (95% CI: 0.621-1.875) 0.787
19-30 0.759 (95% CI: 0.535-1.076) 0.121 0.739 (95% CI: 0.521-1.047) 0.088
31-40 0.617 (95% CI: 0.454-0.838) 0.002 0.614 (95% CI: 0.452-0.835) 0.002
41-50 0.629 (95% CI: 0.475-0.833) 0.001 0.621 (95% CI: 0.469-0.822) 0.001
51-60 0.637 (95% CI: 0.484-0.838) 0.001 0.633 (95% CI: 0.481-0.832) 0.001
61-70 0.679 (95% CI: 0.516-0.893) 0.006 0.673 (95% CI: 0.512-0.885) 0.005
71-80 0.867 (95% CI: 0.653-1.152) 0.326 0.861 (95% CI: 0.648-1.143) 0.301
Above 80 1 1
Gender 0. .972 /
Male 1 / /
Female 0.998 (95% CI:0.885-1.125) / /
Ethnicity 0.207 / /
White 1 / /
Others 0.983 (95% CI: 0.827-1.168) 0.844 / /
Black 0.833 (95% CI: 0.700-0.990) 0.039 / /
Unknown 0.773 (95% CI: 0.320-1.866) 0.567 / /
Histology 0.414
Thymoma 0.941 (95% CI: 0.814-1.088) / /
Thymic carcinoma 1 / /
Masaoka-Koga Stage 0.000 0.000
I-Iva 1
IVb 5.240 (95% CI: 4.495-6.108) 0.000 5.235 (95% CI: 4.491-6.103) 0.000
Unknown 2.759 (95% CI: 2.334-3.261) 0.000 2.756 (95% CI: 2.332-3.257) 0.000
Surgery 0.241
Yes 0.952 (95% CI: 0.838-1.082) 0.455 / /
No 1 / /
unknown 0.644 (95% CI: 0.377-1.099) 0.107 / /